The use of postbiotics as the key ingredient in nutraceuticals is becoming more and more common. This round-up looks at the companies that have made strides in this area, including product innovation and research.
Morinaga Milk Industry has launched a new functional food series containing its clinically studied probiotic strain to improve memory functions in older adults.
In a post-study analysis of Morinaga Milk Industry’s probiotic Bifidobacterium breve MCC1274 (B. breve A1) which was found to significantly improve memory in healthy older subjects in Japan, researchers have discovered the benefits may be due to lower...
Japan’s Morinaga Milk Industry is banking on the confectionery and snacks as emerging formats for its paraprobiotic LAC-Shield (heat-killed Lacticaseibacillus paracasei MCC1849) application.
Morinaga Milk Industry is looking to further expand the application of its probiotic strain, Bifidobacterium longum BB536, into infant nutrition after producing Japan’s first bifidobacterial-fortified infant formula in September this year.
China will continue to cement its standing as Asia’s biggest probiotic market, but an expert panel has predicted that India and South East Asia are the emerging hotspots to watch.
Japan’s Morinaga Milk Industry has obtained a self-affirmed Generally Recognised as Safe (GRAS) status for its Bifidobacterium infantis M-63 probiotic, for use in general foods and infant formula in US.
A randomised control trial on Japan’s Morinaga Milk Industry’s Bifidobacterium breve A1 probiotic strain has shown it could improve memory functions in older adults with mild cognitive impairment (MCI).
Japanese dairy product company Morinaga Milk Industry has revealed plans to expand its yoghurt range by introducing more products with functional benefits, accelerate its lactoferrin research and e-commerce business as part of its key initiatives for...
Japanese firms such as Nippn, Kirin, Morinaga Milk Industry, Kewpie, Yakult, Eminet, and FANCL have been sharing their experiences of operating in Japan despite the state of emergency in the country due to the COVID-19 pandemic.
Morinaga Milk is expanding its powdered infant formula business in Asia specifically Indonesia and Pakistan, as it cites shrinking demand in Japan due to the ageing population.
Research from Morinaga Milk Industry has found that the infant-type human-residential bifidobacteria (HRB) could produce a key metabolite, the immunity-boosting indole-3-lactic acid (ILA), moving one step closer to understanding its benefits on infant...
